Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentSelling, General & Administrative
Others
Ratios

SELLAS Life Sciences (SLS) Cost of Revenue (2021 - 2022)

SELLAS Life Sciences (SLS) has disclosed Cost of Revenue for 2 consecutive years, with $100000.0 as the latest value for Q1 2022.

  • On a quarterly basis, Cost of Revenue changed 0.0% to $100000.0 in Q1 2022 year-over-year; TTM through Dec 2022 was $100000.0, a 50.0% decrease, with the full-year FY2022 number at $100000.0, down 50.0% from a year prior.
  • Cost of Revenue was $100000.0 for Q1 2022 at SELLAS Life Sciences, roughly flat from $100000.0 in the prior quarter.
  • In the past five years, Cost of Revenue ranged from a high of $100000.0 in Q1 2021 to a low of $100000.0 in Q1 2021.